August 14, 2024

The application of Amide proton transfer MR imaging in prostate cancer with different risk

Key Points

Key points are not available for this paper at this time.

Abstract

Amide proton transfer (APT) imaging is a novel nonintrusive technique for the diagnosis of PCa. In this study, we evaluate the distinction between APT value for prostate cancer and benign region in different Gleason scores. The result shows that APT is a potential tool for evaluating the risk of prostate cancer.

AIに質問

Bookmark

Cite This Study

Man et al. (Wed,) studied this question.

synapsesocial.com/papers/68e5c61db6db64358755c9f1 https://doi.org/https://doi.org/10.58530/2023/2063

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Evaluation of Amide Proton Transfer Imaging for Bladder Cancer Histopathologic Features: A Comparative Study with Diffusion- Weighted Imaging2024
2Comparison of 3D amide proton transfer imaging and intravoxel incoherent motion imaging in the diagnosis of prostate cancer2024
3Added value of amid proton transfer weighted MRI to PI-RADS v2.1 in differentiating clinically significant prostate cancer2025
4A pilot application of APT and DWI in differentiating benign and malignant bone and soft tissue tumors: a prospective study2025
5Amide Proton Transfer Weighted Imaging to differentiate prostate suspicious nodules: Comparison with PI-RADS v2.1 score2024

AIに質問

Bookmark